Showing results (201-210 of 388) with videos related to
Sort By:
Pageof 39
Neuro-Oncology Practice|July 19, 2021
Chemotherapy for adult patients with spinal cord gliomasDorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.Neuro-Oncology|August 17, 2019
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trialPascale Varlet, Gwénaël Le Teuff, Marie-Cécile Le Deley, et al.Oncotarget|November 9, 2016
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapyClaudia Paret, Johanna Theruvath, Alexandra Russo, et al.Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.Neoplasia (New York, N.Y.)|July 13, 2012
RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomasAnna von dem Knesebeck, Jörg Felsberg, Anke Waha, et al.Journal of Neurosurgery. Pediatrics|August 3, 2010
Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT databaseMartin Benesch, Daniela Weber-Mzell, Nicolas U Gerber, et al.Acta Neuropathologica|September 2, 2019
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomasFrank Brand, Alisa Förster, Anne Christians, et al.Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on <i>IDH</i> mutation and <i>MGMT</i> promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.Cancer Research|February 4, 2010
Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cellsAnke Waha, Jörg Felsberg, Wolfgang Hartmann, et al.Journal of Neuro-Oncology|February 11, 2011
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006Nicolas U Gerber, Katja von Hoff, André O von Bueren, et al.Pageof 39